Curium Completes the Acquisition of Monrol as Part of its Plan to Significantly Expand Lutetium-177 Capacity and PET Footprint https://www.taxtmi.com/news?id=39233 Curium completed its acquisition of Monrol, adding Monrol's Istanbul manufacturing and logistics operations and workforce to increase Lutetium-177 (Lu-177) production capacity to support Curium's Lu-177 therapeutic candidates, while integrating Monrol's R&D and CMO/CDMO capabilities. Deployment of Monrol's Ga-68 generator and commercial expansion of PET/SPECT sites are planned but conditional on regulatory approvals; the transaction also expands Curium's geographic diagnostic footprint and vertical production and distribution integration. en-us Mon, 31 Mar 2025 17:01:02 +0530 Mon, 31 Mar 2025 17:01:02 +0530 TaxTMI RSS Generator Curium Completes the Acquisition of Monrol as Part of its Plan to Significantly Expand Lutetium-177 Capacity and PET Footprint https://www.taxtmi.com/news?id=39233 Curium completed its acquisition of Monrol, adding Monrol's Istanbul manufacturing and logistics operations and workforce to increase Lutetium-177 (Lu-177) production capacity to support Curium's Lu-177 therapeutic candidates, while integrating Monrol's R&D and CMO/CDMO capabilities. Deployment of Monrol's Ga-68 generator and commercial expansion of PET/SPECT sites are planned but conditional on regulatory approvals; the transaction also expands Curium's geographic diagnostic footprint and vertical production and distribution integration. News - Mon, 31 Mar 2025 17:01:02 +0530 https://www.taxtmi.com/news?id=39233